» Articles » PMID: 27101134

Genotype and Phenotype in Patients with Noonan Syndrome and a RIT1 Mutation

Abstract

Purpose: Noonan syndrome (NS) is an autosomal-dominant disorder characterized by craniofacial dysmorphism, growth retardation, cardiac abnormalities, and learning difficulties. It belongs to the RASopathies, which are caused by germ-line mutations in genes encoding components of the RAS mitogen-activated protein kinase (MAPK) pathway. RIT1 was recently reported as a disease gene for NS, but the number of published cases is still limited.

Methods: We sequenced RIT1 in 310 mutation-negative individuals with a suspected RASopathy and prospectively in individuals who underwent genetic testing for NS. Using a standardized form, we recorded clinical features of all RIT1 mutation-positive patients. Clinical and genotype data from 36 individuals with RIT1 mutation reported previously were reviewed.

Results: Eleven different RIT1 missense mutations, three of which were novel, were identified in 33 subjects from 28 families; codons 57, 82, and 95 represent mutation hotspots. In relation to NS of other genetic etiologies, prenatal abnormalities, cardiovascular disease, and lymphatic abnormalities were common in individuals with RIT1 mutation, whereas short stature, intellectual problems, pectus anomalies, and ectodermal findings were less frequent.

Conclusion: RIT1 is one of the major genes for NS. The RIT1-associated phenotype differs gradually from other NS subtypes, with a high prevalence of cardiovascular manifestations, especially hypertrophic cardiomyopathy, and lymphatic problems.Genet Med 18 12, 1226-1234.

Citing Articles

Clinical features and molecular genetics of patients with RASopathies: expanding the phenotype with rare genes and novel variants.

Yilmaz Uzman C, Gursoy S, Ozkan B, Vuran G, Emecen D, Koprulu O Eur J Pediatr. 2024; 184(1):108.

PMID: 39725732 DOI: 10.1007/s00431-024-05825-8.


Diagnostic Use of Genome Sequencing in Patients With 11p15.5 Imprinting Disorder Features: A Pilot Study.

Kessler L, Krause J, Kraft F, Amin A, Fekete G, Lengyel A Clin Genet. 2024; 107(3):278-291.

PMID: 39663844 PMC: 11790513. DOI: 10.1111/cge.14649.


Refractory Chylothorax and Ventricular Hypertrophy Treated with Trametinib in a Patient with Noonan Syndrome: 18-Month Follow-Up.

Pascarella A, Limongelli G, De Falco A, Minale E, Di Nardo G, Di Marco G Children (Basel). 2024; 11(11).

PMID: 39594917 PMC: 11593188. DOI: 10.3390/children11111342.


Autoinflammation in patients with leukocytic CBL loss of heterozygosity is caused by constitutive ERK-mediated monocyte activation.

Bohlen J, Bagaric I, Vatovec T, Ogishi M, Ahmed S, Cederholm A J Clin Invest. 2024; 134(20).

PMID: 39403923 PMC: 11475086. DOI: 10.1172/JCI181604.


Deciphering the pathogenic role of rare heterozygous missense mutation in the late-presenting DDH.

Liu Y, Fan X, Qian K, Wu C, Zhang L, Yuan L Front Genet. 2024; 15:1375736.

PMID: 38952713 PMC: 11215071. DOI: 10.3389/fgene.2024.1375736.